manysevens It seems you have been away from this company for sometime and are now just catching up to speed with old news. LOL!
I am not sure what you mean by "DNAPrint is quickly becoming synonmous with genetic biotechnology" inasmuch as any and all the players in this field of technology can be said of the same. The predictive medicine initiatives and possible pharma products are still in very basic research, so your enthusiasm about something big happening soon is unwarranted.
I suggest you simplfy your view of this investment by just confining your consideration to the only factor which, IMHO, is of any importance, and that is the pps. It is the final barometric reading of investor sentiment and the only meaningful criteria of this stock as an investment. Everything else is pumping hot air, smoke and mirrors, as history and, of course, the pps have clearly proven to be true.
JMHO from the actual facts.
dr f